An OB-GYN Was Repeatedly Accused of Sexual Misconduct. The State Medical Board Let Him Keep Practicing.

Why It Matters

The case exposes gaps in regulatory oversight that endanger patient safety and erode trust in the healthcare system, prompting calls for stricter disciplinary protocols.

Key Takeaways

• Four complaints filed since 2022, yet doctor practiced
• Commission delayed suspension despite "immediate threat" rule
• Over 80 lawsuits target doctor and health system
• Other states tightening rules on accused physicians
• Advocates demand temporary bans during investigations

Pulse Analysis

The Mulholland saga underscores how Washington’s medical oversight mechanisms can lag behind serious allegations. After the first complaint in early 2022, the state commission received additional reports describing invasive exams and sexually suggestive remarks, yet it chose to issue charges rather than an immediate suspension. This decision allowed the physician to continue treating patients for more than a year, culminating in a flood of lawsuits that allege both personal misconduct and institutional negligence. The delayed response raises questions about the adequacy of existing statutes that require a clear "immediate threat" to justify emergency action.

Nationally, the Mulholland case mirrors a disturbing pattern of OB‑GYN abuse uncovered in institutions such as Columbia University, where hundreds of patients suffered over decades. States like Ohio and Delaware have responded by streamlining the process for temporary license revocations when credible sexual‑misconduct claims arise. These reforms aim to protect vulnerable patients while preserving due‑process rights for physicians. The contrast between proactive policies elsewhere and Washington’s more cautious approach highlights a regulatory gap that could embolden similar misconduct.

For Washington, the fallout may catalyze legislative and procedural changes. Lawmakers and patient‑advocacy groups are urging the medical commission to adopt clearer criteria for interim restrictions, improve transparency of complaint handling, and enforce stricter monitoring of physicians under investigation. Such reforms would not only safeguard patients but also restore confidence in the state’s ability to police professional conduct. As the lawsuits progress, the pressure on regulators to act decisively will likely intensify, setting a precedent for how medical boards nationwide address sexual‑misconduct allegations.